18 \18\Europe/Madrid April \18\Europe/Madrid 2024
Cannabinoids are chemical compounds that act on cannabinoid receptors present in the human body, as well as in the bodies of other mammals. Depending on their origin, they can be classified into: Phytocannabinoids These are compounds that are found only in nature in...
27 \27\Europe/Madrid March \27\Europe/Madrid 2024
How do you see the UK market for both medicinal and recreational cannabis? Medical cannabis is the best kept secret in UK healthcare. We’re a nation of some 67 million people, but a patient population of less than 40,000. Given that there’s around 1.8 million...
29 \29\Europe/Madrid February \29\Europe/Madrid 2024
What are the main challenges to implementing genetics within the medicinal use of cannabis? In our quest for knowledge and solutions, we encounter a fascinating and complex subject: the challenges in implementing cannabis genetics in medicinal use. This field,...
26 \26\Europe/Madrid February \26\Europe/Madrid 2024
Epilepsy is one of the most common neurological disorders, affecting around 70 million people worldwide. 65% of patients are managed with antiepileptic drugs and lead a normal life but, what about the remaining 35%? These patients suffer from refractory epilepsy,...
31 \31\Europe/Madrid January \31\Europe/Madrid 2024
What benefits do you think the implementation of the regulation of medical cannabis in Spain could bring? The nationwide commercial regulation of cannabis provides many benefits that are distinct from merely allowing businesses to exist, like the present status quo in...
10 \10\Europe/Madrid July \10\Europe/Madrid 2023
Which aspect of the GMP design of a medical cannabis industry requires the most attention? I would say the most critical aspect focuses on ensuring strict control of environmental conditions. Maintaining a controlled environment is crucial to ensure product quality,...
